Labcorp Holdings (LH) FY2012 results: revenue $5.7 billion, up 2.3% on the year
Labcorp Holdings Inc. (LH) reported revenue of $5.7 billion for fiscal 2012, the year ended 31 December 2012, up 2.3% on the year before. Net income was $583 million, up 12.2%, and diluted earnings per share $5.99. The figures are the company's own, from the 10-K it filed with the SEC on 26 February 2013.
Revenue
$5.7 billion
+2.3% on the year
FY2007FY2012
Operating margin
18.0%
17.1% a year earlier
FY2007FY2012
Net income
$583 million
+12.2% on the year
FY2007FY2012
Diluted EPS
$5.99
+17.2% on the year
FY2007FY2012
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Revenue
5,671
5,542
5,004
+2.3%
Cost of revenue
3,422
3,268
2,906
+4.7%
Gross profit
2,250
2,275
2,098
-1.1%
Gross margin
39.7%
41.0%
41.9%
Selling, general and administrative
1,115
1,160
1,034
-3.9%
Operating income
1,024
948
979
+7.9%
Operating margin
18.0%
17.1%
19.6%
Interest expense
94.5
87.5
70.0
+8.0%
Income tax
359
333
344
+7.9%
Net income
583
520
558
+12.2%
Net margin
10.3%
9.4%
11.2%
Diluted EPS
$5.99
$5.11
$5.29
+17.2%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Operating cash flow
841
856
884
-1.7%
Capital expenditure
174
146
126
+19.3%
Free cash flow
668
710
758
-6.0%
Free cash flow margin
11.8%
12.8%
15.1%
Cash from investing
-534
-280
-1,318
Cash from financing
-0.8
-645
515
Depreciation and amortisation
230
231
204
-0.7%
Share-based compensation
40.7
48.9
40.0
-16.8%
Buybacks
516
644
338
-19.8%
Diluted shares, weighted
97m
102m
105m
-4.3%
Shares outstanding at period end
94m
98m
102m
-4.4%
Balance sheet
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Shareholders' equity
4,945
2,504
2,466
+97.5%
Debt
2,655
2,221
1,827
+19.5%
Other liabilities
n/a
1,387
1,895
Total liabilities and equity
6,795
6,112
6,188
+11.2%
Fixed assets
631
578
587
+9.1%
Goodwill
2,902
2,682
2,601
+8.2%
Intangible assets
1,668
1,621
1,674
+2.9%
Cash and equivalents
404
159
159
+153.6%
Receivables
718
700
656
+2.7%
Inventory
121
111
103
+9.2%
Other assets
351
261
407
+34.5%
Total assets
6,795
6,112
6,188
+11.2%
10-K for the year ended 31 December 2012, filed 26 February 2013: the filing.